BayMark, Webster-backed opioid-treatment company, preps for sales process

2 January 2019•3 mins read
Baymark Health Services, Webster Capital, opioid treatment, addiction, healthcare, private equity, merger, M&A
LinkedInXEmail
LinkedInXEmail

Related articles